Drug Profile
AKF 1
Alternative Names: AKF-1Latest Information Update: 26 Nov 2015
Price :
$50
*
At a glance
- Originator Akorn
- Class Antiallergics; Eye disorder therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Allergic conjunctivitis
Most Recent Events
- 26 Nov 2015 No recent reports on development identified - Phase-III for Allergic conjunctivitis in USA (Ophthalmic)